Quantcast Pfizer Anxiety
Search by tag or site Login to my blogStart my own blog















TheMoneyBlogs
Home
About
Create your own blog
Contact us
Vote for this blog!

Financial Skeptic

Accentuating the caveat emptor with critical commentary concerning investor relations and financial communications. I look at how information is (mis)managed and manipulated thereby creating possible investors losses.

Pfizer Anxiety

Posted on 01/23/2007 06:33 AM | Link | Post Comment
Well the big Pfizer (NYSE:PFE) press release came and went. We all knew they were going to make a big splash. They had to. The communique was structured with five priority points. The first three were predictable and most people probably understood them. Reading on my skepticism started to kick in.

“Priority Four: Actively and more meaningfully engage with customers, patients, physicians and other collaborators to provide them with greater value”. The press release went on to say that they would seek out new approaches to bring products to market.

As best I can tell the FDA and drug regulators in other countries have not changed how they operate. The whole area of pharmaceutical marketing remains controversial and some would say ethically challenged. Also an awful lot of your sales force is becoming unemployed and have lost the employment lottery. Those who keep their jobs may have lost motivation.

Investors clearly need to know how priority four is to be implemented. Right know we only know what they will not be doing.

“Priority Five: Make Pfizer a great place to work.” This is just a motherhood filler which does not have any integrity. You are axing committees and flattening the organizational structure. That will make the place more efficient. Sounds like a run on comment to priority point three, which is to create smaller, more focused and entrepreneurial business units.

Pfizer is still taking tentative steps and is not truly as confident as it seems. A focused three-point plan would have more convincingly indicated strategic clarity of purpose. Perhaps the most critical line in the press release was “Long Term Outlook -- 2009-10 Resumption of Revenue Growth Given Contribution of New and In-Line Products and Dissipation of Loss of Exclusivity Impact” Its still a little ways out before the good times have permission to roll. The market is going to need some more good news
Stock Quote or
Examples
Morpheus Trading - Thu Jul 17, 2008 01:15AM
NOTE: Please click on the charts below to enlarge them if th [read more]
Morpheus Trading - Tue Jul 15, 2008 08:25AM
NOTE: Please click on the charts below to enlarge them [read more]
Morpheus Trading - Mon Jul 14, 2008 02:18AM
NOTE: Please click on the charts below to enlarge them if [read more]

PREMIER SPONSORED LINKS

Most Visited Blogs | Most Popular Blogs | Most Recent Blogs | Contact Us | Terms and conditions | Privacy Policy

The columns, articles, message board posts and any other features provided on TheMoneyBlogs.com are provided for personal finance, education and investment information and are not to be construed as investment advice. Under no circumstances does the information in this content represent a recommendation to buy, sell or hold any security. The views and opinions expressed in an article or column are the author's own and not necessarily those of TheMoneyBlogs.com and there is no implied endorsement by TheMoneyBlogs.com of any advice or trading strategy. The analysts and employees or affiliates of TheMoneyBlogs.com may hold positions in the stocks or industries discussed here. Your use of this and all information contained on TheMoneyBlogs.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

Copyright © 2008 The Connors Group, Inc.